Login to Your Account



Arena Pushes for Lorcaserin Approval Despite FDA Letter

By Marie Powers


Thursday, December 23, 2010
Arena Pharmaceuticals Inc. has vowed to press forward for approval of its weight loss drug lorcaserin despite the FDA's issuance of a complete response letter (CRL) in October.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription